Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
KES | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,297 | 1,186 | 1,077 | 968 | 967 | 976 | 1,098 | 1,382 | 1,287 | 1,539 | | 1,473 |
% Growth | NA | -8.5% | -9.2% | -10.1% | -0.1% | 1.0% | 12.5% | 25.8% | -6.8% | 19.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (668) | (603) | (524) | (466) | (486) | (547) | (617) | (822) | (763) | (783) | | (751) |
Gross Profit | 629 | 583 | 553 | 501 | 480 | 429 | 481 | 560 | 524 | 756 | | 722 |
% Revenue | 48.5% | 49.2% | 51.3% | 51.8% | 49.7% | 44.0% | 43.8% | 40.5% | 40.7% | 49.1% | | 49.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (112) | (101) | (103) | (112) | (111) | (95) | (102) | (105) | (131) | (159) | | (159) |
General and Admin | (319) | (325) | (319) | (349) | (306) | (298) | (267) | (326) | (217) | (328) | | (300) |
Other Inc / (Exp) | 16 | (9) | (9) | (30) | (16) | 2 | 8 | (1) | 1 | 13 | | 13 |
Total Operating Exp | (415) | (436) | (431) | (490) | (433) | (391) | (361) | (432) | (347) | (474) | | (445) |
| | | | | | | | | | | | |
Operating Income | 214 | 148 | 122 | 11 | 47 | 38 | 120 | 128 | 178 | 283 | | 277 |
% Revenue | 16.5% | 12.4% | 11.3% | 1.1% | 4.9% | 3.9% | 11.0% | 9.3% | 13.8% | 18.4% | | 18.8% |
| | | | | | | | | | | | |
Interest Expense | 63 | 74 | 69 | 73 | 72 | 52 | 36 | 41 | 36 | 27 | | 46 |
Pre-tax Income | 278 | 222 | 191 | 84 | 120 | 90 | 156 | 169 | 213 | 309 | | 322 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (48) | (73) | (64) | (44) | (54) | (34) | (55) | (61) | (65) | (111) | | (113) |
Net Income to Company | 230 | 149 | 126 | 39 | 66 | 56 | 102 | 108 | 148 | 198 | | 209 |
% Margin | 17.7% | 12.5% | 11.7% | 4.1% | 6.8% | 5.7% | 9.3% | 7.8% | 11.5% | 12.9% | | 14.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 230 | 149 | 126 | 39 | 66 | 56 | 102 | 108 | 148 | 198 | | 209 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 230 | 149 | 126 | 39 | 66 | 56 | 102 | 108 | 148 | 198 | | 209 |
% Margin | 17.7% | 12.5% | 11.7% | 4.1% | 6.8% | 5.7% | 9.3% | 7.8% | 11.5% | 12.9% | | 14.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 11.76 | 7.61 | 6.47 | 2.02 | 3.36 | 2.86 | 5.21 | 5.55 | 7.58 | 10.14 | | 10.72 |
Diluted EPS (Continuing Ops) | 11.76 | 7.61 | 6.47 | 2.02 | 3.36 | 2.86 | 5.21 | 5.55 | 7.58 | 10.14 | | 10.72 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | | 19.56 |
WA Diluted Shares Out. | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | 19.53 | | 19.56 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 278 | 222 | 191 | 84 | 120 | 90 | 156 | 169 | 213 | 309 | | 322 |
Addback: Net Interest Expense | (63) | (74) | (69) | (73) | (72) | (52) | (36) | (41) | (36) | (27) | | (46) |
Addback: Other Non Operating Expenses, Total | (14) | 13 | 10 | 19 | 2 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 49 | 71 | 71 | 79 | 85 | 99 | 95 | 96 | 93 | 85 | | 82 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 20 | 17 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (3) | (3) | (2) | (9) | (2) | (2) | (8) | 1 | (1) | (13) | | (13) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 247 | 228 | 201 | 119 | 148 | 135 | 207 | 225 | 269 | 355 | | 346 |
% Margin | 19.1% | 19.3% | 18.7% | 12.3% | 15.3% | 13.8% | 18.8% | 16.3% | 20.9% | 23.1% | | 23.5% |
| | | | | | | | | | | | |
Adjusted EBIT | 198 | 157 | 131 | 40 | 64 | 36 | 112 | 129 | 177 | 270 | | 264 |
% Margin | 15.3% | 13.2% | 12.1% | 4.2% | 6.6% | 3.7% | 10.2% | 9.3% | 13.7% | 17.5% | | 17.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 230 | 149 | 126 | 39 | 66 | 56 | 102 | 108 | 148 | 198 | | 209 |
Addback: Unusual Items | (3) | (3) | (2) | 11 | 14 | (2) | (8) | 1 | (1) | (13) | | (13) |
Less: Tax Benefit of Unusual Items (26%) | 1 | 1 | 0 | (3) | (4) | 1 | 2 | (0) | 0 | 3 | | 3 |
Adjusted Net Income | 228 | 146 | 125 | 47 | 76 | 54 | 95 | 109 | 147 | 189 | | 200 |
% Margin | 17.6% | 12.3% | 11.6% | 4.9% | 7.9% | 5.6% | 8.7% | 7.9% | 11.4% | 12.2% | | 13.6% |